[Cytokines in bone diseases. BMP signaling and fibrodysplasia ossificans progressiva].

Takenobu Katagiri, Jyunji Kamizono, Yasuharu Nakashima, Hiroshi Kitoh, Takafumi Susami, Nobuhiko Haga

Research output: Contribution to journalReview article

1 Citation (Scopus)

Abstract

Fibrodysplasia ossificans progressiva (FOP) is a rare autosomal dominant disorder characterized by progressive heterotopic bone formation in skeletal muscle tissue. In 2007, FOP was authorized as one of the Intractable Disorders by the Ministry of Health, Labour and Welfare of Japan. The Research Committee on FOP is working on the molecular mechanisms underlying heterotopic bone formation and the development of new treatments for FOP.

Original languageEnglish
Pages (from-to)1510-1517
Number of pages8
JournalClinical calcium
Volume20
Issue number10
Publication statusPublished - Jan 1 2010

Fingerprint

Myositis Ossificans
Bone Diseases
Cytokines
Osteogenesis
Bone Development
Japan
Skeletal Muscle
Muscles
Health
Research

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Katagiri, T., Kamizono, J., Nakashima, Y., Kitoh, H., Susami, T., & Haga, N. (2010). [Cytokines in bone diseases. BMP signaling and fibrodysplasia ossificans progressiva]. Clinical calcium, 20(10), 1510-1517.

[Cytokines in bone diseases. BMP signaling and fibrodysplasia ossificans progressiva]. / Katagiri, Takenobu; Kamizono, Jyunji; Nakashima, Yasuharu; Kitoh, Hiroshi; Susami, Takafumi; Haga, Nobuhiko.

In: Clinical calcium, Vol. 20, No. 10, 01.01.2010, p. 1510-1517.

Research output: Contribution to journalReview article

Katagiri, T, Kamizono, J, Nakashima, Y, Kitoh, H, Susami, T & Haga, N 2010, '[Cytokines in bone diseases. BMP signaling and fibrodysplasia ossificans progressiva].', Clinical calcium, vol. 20, no. 10, pp. 1510-1517.
Katagiri T, Kamizono J, Nakashima Y, Kitoh H, Susami T, Haga N. [Cytokines in bone diseases. BMP signaling and fibrodysplasia ossificans progressiva]. Clinical calcium. 2010 Jan 1;20(10):1510-1517.
Katagiri, Takenobu ; Kamizono, Jyunji ; Nakashima, Yasuharu ; Kitoh, Hiroshi ; Susami, Takafumi ; Haga, Nobuhiko. / [Cytokines in bone diseases. BMP signaling and fibrodysplasia ossificans progressiva]. In: Clinical calcium. 2010 ; Vol. 20, No. 10. pp. 1510-1517.
@article{72ba184822364bb38446d0a6622e40c5,
title = "[Cytokines in bone diseases. BMP signaling and fibrodysplasia ossificans progressiva].",
abstract = "Fibrodysplasia ossificans progressiva (FOP) is a rare autosomal dominant disorder characterized by progressive heterotopic bone formation in skeletal muscle tissue. In 2007, FOP was authorized as one of the Intractable Disorders by the Ministry of Health, Labour and Welfare of Japan. The Research Committee on FOP is working on the molecular mechanisms underlying heterotopic bone formation and the development of new treatments for FOP.",
author = "Takenobu Katagiri and Jyunji Kamizono and Yasuharu Nakashima and Hiroshi Kitoh and Takafumi Susami and Nobuhiko Haga",
year = "2010",
month = "1",
day = "1",
language = "English",
volume = "20",
pages = "1510--1517",
journal = "Clinical calcium",
issn = "0917-5857",
publisher = "Iyaku (Medicine & Drug) Journal Co",
number = "10",

}

TY - JOUR

T1 - [Cytokines in bone diseases. BMP signaling and fibrodysplasia ossificans progressiva].

AU - Katagiri, Takenobu

AU - Kamizono, Jyunji

AU - Nakashima, Yasuharu

AU - Kitoh, Hiroshi

AU - Susami, Takafumi

AU - Haga, Nobuhiko

PY - 2010/1/1

Y1 - 2010/1/1

N2 - Fibrodysplasia ossificans progressiva (FOP) is a rare autosomal dominant disorder characterized by progressive heterotopic bone formation in skeletal muscle tissue. In 2007, FOP was authorized as one of the Intractable Disorders by the Ministry of Health, Labour and Welfare of Japan. The Research Committee on FOP is working on the molecular mechanisms underlying heterotopic bone formation and the development of new treatments for FOP.

AB - Fibrodysplasia ossificans progressiva (FOP) is a rare autosomal dominant disorder characterized by progressive heterotopic bone formation in skeletal muscle tissue. In 2007, FOP was authorized as one of the Intractable Disorders by the Ministry of Health, Labour and Welfare of Japan. The Research Committee on FOP is working on the molecular mechanisms underlying heterotopic bone formation and the development of new treatments for FOP.

UR - http://www.scopus.com/inward/record.url?scp=79952197256&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952197256&partnerID=8YFLogxK

M3 - Review article

C2 - 20890033

AN - SCOPUS:79952197256

VL - 20

SP - 1510

EP - 1517

JO - Clinical calcium

JF - Clinical calcium

SN - 0917-5857

IS - 10

ER -